Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients - Quiz - MDSpire

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients

  • By

  • Song Cheng

  • Dabin Chen

  • Rongrong Du

  • Chao Wang

  • Jiawen Xian

  • Liyuan Liu

  • Hong Wan

  • Ting Ye

  • May 26, 2026

  • 0 min

Share

Original Source(s)

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients

  • by Song Cheng, Dabin Chen, Rongrong Du, Chao Wang, Jiawen Xian, Liyuan Liu, Hong Wan, Ting Ye

  • May 26, 2026

Related Content

Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

Editorial: Epigenetic modulation in cancer

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size